Silverback Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $688k | 65k | 10.55 |
| 2024-09-30 | $918k | 63k | 14.50 |
| 2024-06-30 | $561k | 66k | 8.51 |
| 2024-03-31 | $379k | 37k | 10.22 |
| 2023-12-31 | $199k | 36k | 5.48 |
| 2023-09-30 | $137k | 36k | 3.78 |
| 2023-06-30 | $231k | 34k | 6.70 |
| 2022-03-31 | $85k | 24k | 3.53 |
| 2021-12-31 | $141k | 21k | 6.64 |
| 2021-09-30 | $200k | 20k | 9.99 |
| 2021-06-30 | $515k | 17k | 30.88 |
| 2021-03-31 | $575k | 13k | 43.60 |